epidermolysis bullosa

Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to epidermolysis bullosa: Epidermolysis bullosa simplex

Epidermolysis Bullosa



Epidermolysis bullosa (EB) is a group of rare inherited skin diseases that are characterized by the development of blisters following minimal pressure to the skin. Blistering often appears in infancy in response to simply being held or handled. In rarer forms of the disorder, EB can be life-threatening. There is no cure for the disorder. Treatment focuses on preventing and treating wounds and infection.


Epidermolysis bullosa has three major forms and at least 16 subtypes. The three major forms are EB simplex, junctional EB, and dystrophic EB. These can range in severity from mild blistering to more disfiguring and life-threatening disease. Physicians diagnose the form of the disease based on where the blister forms in relation to the epidermis (the skin's outermost layer) and the deeper dermis layer.
The prevalence of epidermolysis varies among different populations. A study in Scotland estimated the prevalence to be one in 20,400. Researchers in other parts of the world estimate the prevalence to be one in 100,000. This variance is due to the variability of expression. Many cases of epidermolysis bullosa are often not accurately diagnosed and thus, are not reported.

Causes and symptoms

EB can be inherited as the result of a dominant genetic abnormality (only one parent carries the abnormal gene) or a recessive genetic abnormality (both parents carry the abnormal gene).
EB simplex results from mutations in genes responsible for keratin 5 and 14, which are proteins that give cells of the epidermis its structure. EB simplex is transmitted in an autosomal dominant fashion.
Dystrophic EB is caused by mutations in genes for type VII collagen, the protein contained in the fibers anchoring the epidermis to the deeper layers of the skin. The genetic mutations for junctional EB are found in the genes responsible for producing the protein Laminin-5. Dystrophic EB is an autosomal disorder and will only result if both parents transmit an abnormal gene during conception.
EB simplex, the most common form of EB, is the least serious form of the disease. In most affected individuals, the blisters are mild and do not scar after they heal. Some forms of EB simplex affect just the hands and feet. Other forms of EB simplex can lead to more widespread blistering, as well as hair loss and missing teeth. Recurrent blistering is annoying but not life threatening.
The second, or junctional, form of EB does not lead to scarring. However, skin on the areas prone to blistering, such as elbows and knees, often shrinks. In one variation of junctional EB, called gravis junctional EB of Herlitz, the blistering can be so severe that affected infants may not survive due to massive infection and dehydration.
The third form of EB, dystrophic EB, varies greatly in terms of severity, but more typically affects the arms and legs. In one variation, called Hallopeau-Siemens EB, repeated blistering and scarring of the hands and feet causes the fingers and toes to fuse, leaving them dysfunctional and with a mitten-like appearance.


Physicians and researchers distinguish between the three major subtypes of EB based on which layer of the epidermis separates from the deeper dermis layer of the skin below. Patients suspected of having EB should have a fresh blister biopsied for review. This sample of tissue is examined under an electron microscope or under a conventional microscope using a technique called immunofluorescence, which helps to map the underlying structure.
Knowing that a family member has EB can help establish the diagnosis, but it is possible that parents or siblings will show no sign of the disease, either because it is caused by a new genetic mutation, or because the parents are carriers of the recessive trait and do not display the disease.

Key terms

Collagen — The main supportive protein of cartilage, connective tissue, tendon, skin, and bone.
Dermis — The layer of skin beneath the epidermis.
Epidermis — The outermost layer of the skin.
Keratin — A tough, nonwater-soluble protein found in the nails, hair, and the outermost layer of skin. Human hair is made up largely of keratin.


The most important treatment for EB is daily wound care. Because the skin is very fragile, care must be taken to be certain that dressing changes do not cause further damage. Tape should not be applied directly to skin and bandages should be soaked off. Infection is a major concern, so a topical antibiotic, such as bacitracin, mupirocin, or sulfadiazine, should be routinely applied. Among persons with recessive dystrophic EB, the anticonvulsant phenytoin is sometimes effective because it decreases production of an enzyme that breaks down collagen.


The prognosis of EB varies depending on the subtype of the disease. Individuals with EB simplex can live long, fulfilling lives. The severity of the junctional and dystrophic forms of EB can vary greatly. Infants affected with some forms of the disease often do not survive infancy; other forms can lead to severe scarring and disfigurement.



Fine, Jo-David, et al. Epidermolysis Bullosa: Clinical,Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins Univ Press, 1999.
Fitzpatrick, Thomas B., Richard A. Johnson, Wolff Klaus, and Dick Suurmond. Color Atlas and Synopsis of Clinical Dermatology. 4th ed. NewYork: McGraw-Hill, 2000.
Mallory, S.B. Atlas of Pediatric Dermatology. Pearl River, NY: Parthenon, 2001.


Cotell, S., N. D. Robinson, and L. S. Chan. "AutoimmuneBlistering Skin Diseases." American Journal of Emerging Medicine 18, no. 3 (2000): 288-99.


American Academy of Dermatology. PO Box 4014, 930 N. Meacham Rd., Schaumburg, IL 60168-4014. (847) 330-0230. Fax: (847) 330-0050. http://www.aad.org.


Dermatology Online Atlas. 〈http://www.dermis.net/doia/diagnose.asp?zugr=d&lang=e&diagnr=757320&topic=t〉.
Dystrophic Epidermolysis Bullosa Research Association International. 〈http://debra-international.org/index1.htm〉.
Epidermolysis Bullosa Medical Research Foundation. http://www.med.stanford.edu/school/dermatology/ebmrf/.
Oregon Health Sciences University. 〈http://www.ohsu.edu/cliniweb/C17/C17.800.865.410.html〉.
University of Iowa College of Medicine. http://tray.dermatology.uiowa.edu/EBA-001.htm.


a loosened state of the epidermis with formation of blebs and bullae either spontaneously or at the site of trauma.
epidermolysis bullo´sa a variety with development of bullae and vesicles, often at the site of trauma; in the hereditary forms, there may be severe scarring after healing, or extensive denuded areas after rupture of the lesions.

ep·i·der·mol·y·sis bul·lo·'sa

a group of inherited chronic noninflammatory skin diseases in which large bullae and erosions result from slight mechanical trauma; a form localized to the hands and feet is called Weber-Cockayne syndrome, of autosomal dominant inheritance caused by mutation in either the gene encoding keratin-5 (KRT5) on chromosome 12q or the gene for keratin-14 (KRT14) on 17q.

epidermolysis bullosa

Etymology: Gk, epi + derma + lysis, loosening
a group of rare hereditary skin diseases in which vesicles and bullae develop, usually at sites of trauma. Severe forms may also involve mucous membranes and may leave scars and contractures on healing. Basal cell and squamous cell carcinomas sometimes develop in the scar tissue.
enlarge picture
Junctional epidermolysis bullosa

epidermolysis bullosa

Epidermolysis bullosa, epidermolysis bullosa lethalis, Epidermolysis bullosa simplex, Weber-Cockayne syndrome Pediatrics A general term for an array of dermatopathies with manifestations ranging from minor blisters of mucocutaneous surfaces, to formation of large bullae which may appear following minor trauma, that later rupture, leaving scars and dysphagia

ep·i·der·mol·y·sis bul·lo·sa

(ep'i-dĕr-mol'i-sis bul-ō'să)
A group of inherited chronic noninflammatory skin diseases in which large bullae and erosions result from slight mechanical trauma; a form limited to the hands and feet is also called Weber-Cockayne syndrome.

epidermolysis bullosa

One of a group of genetic disorders causing blistering of the skin and mucous membranes. In simple cases the blistering is induced by injury, but in serious cases it occurs spontaneously


Johannes Karl August Eugen Alfred, German neurologist, 1858-1935.
Goldscheider disease - loosening of the epidermis with formation of bullae. Synonym(s): epidermolysis bullosa
Goldscheider test - determination of the temperature sense by touching the skin with a sharp-pointed metallic rod, heated to varying degrees.

epidermolysis bullosa

; EB group of autosomal-recessive disorders characterized by skin fragility and blistering in response to innocuous or minor trauma, due to the pathological weakening of epidermal-dermal junction and formation of large blood-filled blisters (bullae) leading to severe fibrosis, scarring and contracture of skin, digital fusion and loss of epidermal appendages; sufferers are often treated with corticosteroids

ep·i·der·mol·y·sis bul·lo·sa

(ep'i-dĕr-mol'i-sis bul-ō'să)
Group of inherited chronic noninflammatory skin diseases in which large bullae and erosions result from slight mechanical trauma.

epidermolysis bullosa (ep´idur-mol´isis),

n a disease of the skin characterized by bullae, vesicles, cysts, and, often, associated mandibular enlargement. See also syndrome, Goldscheider's and syndrome, Weber-Cockayne.
Enlarge picture
Epidermolysis bullosa.


a loosened state of the epidermis with formation of blebs and bullae either spontaneously or at the site of trauma.

epidermolysis bullosa
a hereditary disease of humans, Collie dogs, Shetland sheepdogs, Suffolk, South Dorset Down and Scottish blackface sheep, and Simmental and Brangus calves. Characterized by epidermal bullae, particularly on areas of pressure or trauma and in sheep in the mouth and on woolless skin. There may be shedding of hooves and horns. Called also red foot disease.
congenital bovine epidermolysis
ulcers on lips, gums, tongue, muzzle and limb extremities at birth; skin lesions may be local alopecia without ulceration; resembles epidermolysus bullosa simplex in humans; an autosomal dominant recorded in Simmentals.
References in periodicals archive ?
About DebRA The Dystrophic Epidermolysis Bullosa Research Association of America (DebRA), is the only national non-profit dedicated to funding research and providing services and programs for those with Epidermolysis Bullosa (EB) - The Worst Disease You've Never Heard Of.
Proceeds from the event benefit d eb ra of America , the only national nonprofit dedicated to funding research for treatments and a cure, while providing supportive services and programs for those who suffer from the rare and painful genetic disorder, Epidermolysis Bullosa.
Scioderm's main focus is the treatment of Epidermolysis Bullosa (EB).
Mats has been instrumental in helping d eb ra of America raise awareness for Epidermolysis Bullosa and funds for research and the supportive services and programs.
Alan Arbuckle, MD, Section Head Pediatric Dermatology Kaiser Permanente Colorado, Wound Care Consultant, Epidermolysis Bullosa Center of Excellence, The Children's Hospital, Aurora Colorado.
The work was sponsored in part by the Department of Veterans Affairs, the Epidermolysis Bullosa Medical Research Foundation, a Schroedinger grant from the FWF of Austria and grants from the National Institutes of Health.
will be holding the biennial DebRA Patient Care Conference(PCC) for the children and families affected by Epidermolysis Bullosa (EB) from July 30 through August 1 at the Gaylord Palms Resort and Convention Center in Orlando/Kissimmee, Florida.
com) announced it is clear to begin its third Phase II clinical trial to test its drug, Thymosin beta 4 (TB4), for the treatment of patients with epidermolysis bullosa (EB).
June 19, 2012 /PRNewswire-iReach/ -- Scioderm today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of topical administration of SD-101, a dermal pharmaceutical in development for treatment of chronic wounds and lesions in children with various types of Epidermolysis Bullosa.
In 2004, TB4 was designated an "Orphan Drug" by the FDA for the treatment of patients with epidermolysis bullosa.
Most of the patients enrolled in the Australian trials were patients suffering from Epidermolysis Bullosa (EB), a rare genetic disorder which causes major breakdowns of the skin similar to those caused by severe burns.
19, 2015 /PRNewswire/ -- EB Research Partnership("EBRP") -- the nation's largest not-for-profit organization dedicated to curing epidermolysis bullosa ("EB"), a rare and debilitating skin disorder -- announced today that it has secured a $3 million individual gift from the Deshe Family, the largest of its kind ever given to an EB-related cause.

Full browser ?